Radiofrequency Ablation (RFA) for Osteoid Osteoma in an 11-Year-Old Male Child With Sickle Cell Trait: A Case Report

Cureus. 2024 Jul 1;16(7):e63626. doi: 10.7759/cureus.63626. eCollection 2024 Jul.

Abstract

Osteoid osteoma is a benign bone tumor that typically presents with nocturnal pain alleviated by nonsteroidal anti-inflammatory medications. The coexistence of osteoid osteoma with sickle cell anemia, a hereditary hemoglobinopathy characterized by vaso-occlusive crises and bone infarcts, poses diagnostic and therapeutic challenges due to overlapping clinical and radiological features. This condition primarily involves the long bones of the lower extremities, particularly the femur and tibia. Despite its benign nature, osteoid osteoma can significantly impact a patient's quality of life due to persistent and intense pain, often leading to substantial sleep disturbances and functional limitations.

Keywords: nonsteroidal anti-inflammatory drugs (nsaids); osteoid osteoma; prostaglandin; radiofrequency ablation; sickle cell trait.

Publication types

  • Case Reports